New brief therapy aims to help veterans in opioid recovery find purpose
NCT ID NCT05189223
First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This study is testing a short, values-based therapy for Veterans who have recently started medication for opioid use disorder (like buprenorphine). The therapy focuses on helping them clarify their personal values, set goals, and improve social connections. The study has three phases: first, developing the therapy with input from Veterans and providers; second, testing it with 10 Veterans; and third, comparing it to usual care in a pilot trial with 40 Veterans. The goal is to see if this approach is feasible and acceptable, and whether it can improve quality of life and social functioning during early recovery.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- brief values-based behavioral intervention
- What this could lead to
- If it works, this could provide a practical, short-term therapy to help Veterans in early opioid treatment rebuild their social lives and sense of purpose.
- What could go wrong
- This is a very small, early-phase pilot study (50 participants total) testing feasibility and acceptability, not effectiveness. The intervention is brief and may not produce lasting changes.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for DEPENDENCE, OPIOID are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
VA Bedford HealthCare System, Bedford, MA
RECRUITINGBedford, Massachusetts, 01730-1114, United States